Last reviewed · How we verify
Evaluation of Updated Continuous Glucose Monitoring (CGM) Form Factor in Adults, Adolescents and Pediatrics
The purpose of this study is to demonstrate the performance of the Disposable Sensor (DS5) in subjects age 2 - 80 years, for the span of 170 hours (7 days).
Details
| Lead sponsor | Medtronic MiniMed, Inc. |
|---|---|
| Phase | NA |
| Status | COMPLETED |
| Enrolment | 317 |
| Start date | Wed Jul 15 2020 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Tue Apr 12 2022 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Type 1 Diabetes Mellitus
- Type 2 Diabetes Mellitus
Interventions
- Continuous Glucose Monitoring
Countries
China, United States